Home
>
National Drug Code (NDC)
>
Pyridostigmine Bromide
Pyridostigmine Bromide - 0179-0070-70 - (Pyridostigmine Bromide)
Drug Information of Pyridostigmine Bromide
| Product NDC: | 0179-0070 |
| Proprietary Name: | Pyridostigmine Bromide |
| Non Proprietary Name: | Pyridostigmine Bromide |
| Active Ingredient(s): | 60 mg/1 & nbsp; Pyridostigmine Bromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pyridostigmine Bromide
| Product NDC: | 0179-0070 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040457 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100802 |
Package Information of Pyridostigmine Bromide
| Package NDC: | 0179-0070-70 |
| Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0070-70) |
NDC Information of Pyridostigmine Bromide
| NDC Code | 0179-0070-70 |
| Proprietary Name | Pyridostigmine Bromide |
| Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0070-70) |
| Product NDC | 0179-0070 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pyridostigmine Bromide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100802 |
| Marketing Category Name | ANDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
